glp-1 news 48 hours Weight-Loss Drug Demonstration Begins July 2026 The weight-loss-independent hepatoprotective benefits of

Whether GLP-1s are covered by insurance has huge implications nationally because the drugs, which were first approved to treat diabetes and later obesity, are also being studied for possible future treatment of a wide range of other conditions, from kidney disease to Alzheimers to substance abuse disorder, thus accelerating demand

You may be a good candidate if you experience frequent hunger or cravings, difficulty losing weight despite consistent effort, or a pattern of weight regain after dieting

It plays a role in: Binding and neutralizing reactive compounds Supporting enzymatic detoxification pathways Assisting the breakdown of metabolic byproducts These processes are part of normal physiological function and occur continuously in the body

We expect GLP-1 and other anti-obesity drugs to have a lasting influence in the food and nutrition landscape, General Mills CEO Jeffrey Harmening said at a recent industry conference, pointing to consumer movement toward smaller portions and more protein- and fiber-rich foods

Similarly, in spite of the fact that many GLP-1 drugs are approved by FDA, none of these companies had an FDA approval or, for example, a license to manufacture and distribute them from the drug companies that do

634/2017 and 1053/2021) and by the Madrid Regional authorities (ref